Literature DB >> 18376572

Seroprevalence of HHV8 in a cohort of HIV-negative and HIV-positive patients in Mozambique.

S Ceffa1, E Buonomo, A M Doro Altan, F Erba, P Germano, G Guidotti, G Liotta, M Magnano San Lio, P Scarcella, L Palombi, M C Marazzi.   

Abstract

Kaposi Sarcoma shows several different clinical and epidemiological patterns. In Sub-Saharan Africa, where the HIV achieves an high prevalence of infection, the KS can be found both in HIV positive than in HIV negative patients, and the diffusion of the HHV8 virus is endemic. The aim of the work is to evaluate the HHV8 seroprevalence in Mozambique. Moreover the relationship of some main indicators, as CD4 and CD8 cells count, HIV viral load, Body Mass Index and haemoglobin values have been calculated in a part of the DREAM Cohort, (HIV positive patients enrolled in the Community of Sant'Egidio program to fight AIDS in the Sub-Saharan Africa). In the HIV positive cohort HHV8 negative and HHV8 positive groups show statistical significance (p < 0.05) in CD4 cells count, a strong significance (p = 0.01) in CD8 cells count and a significance also in Haemoglobin levels (p = 0.35). The difference in Haemoglobin levels (0.5 g/dl) is related more to a statistical than a clinical significance. The study confirms the free circulation of the HHV8 virus in the Mozambican population, with a prevalence rate of 51.1%, similar than that measured in bordering countries. Considering the CD8 value within the HIV positive sub-cohort a strong correlation with the positivity for HHV8 and the immunological status is suggested.

Entities:  

Mesh:

Year:  2007        PMID: 18376572

Source DB:  PubMed          Journal:  Ann Ig        ISSN: 1120-9135


  2 in total

Review 1.  Association of HIV and ART with cardiometabolic traits in sub-Saharan Africa: a systematic review and meta-analysis.

Authors:  David G Dillon; Deepti Gurdasani; Johanna Riha; Kenneth Ekoru; Gershim Asiki; Billy N Mayanja; Naomi S Levitt; Nigel J Crowther; Moffat Nyirenda; Marina Njelekela; Kaushik Ramaiya; Ousman Nyan; Olanisun O Adewole; Kathryn Anastos; Livio Azzoni; W Henry Boom; Caterina Compostella; Joel A Dave; Halima Dawood; Christian Erikstrup; Carla M Fourie; Henrik Friis; Annamarie Kruger; John A Idoko; Chris T Longenecker; Suzanne Mbondi; Japheth E Mukaya; Eugene Mutimura; Chiratidzo E Ndhlovu; George Praygod; Eric W Pefura Yone; Mar Pujades-Rodriguez; Nyagosya Range; Mahmoud U Sani; Aletta E Schutte; Karen Sliwa; Phyllis C Tien; Este H Vorster; Corinna Walsh; Rutendo Zinyama; Fredirick Mashili; Eugene Sobngwi; Clement Adebamowo; Anatoli Kamali; Janet Seeley; Elizabeth H Young; Liam Smeeth; Ayesha A Motala; Pontiano Kaleebu; Manjinder S Sandhu
Journal:  Int J Epidemiol       Date:  2013-12       Impact factor: 7.196

2.  Outcomes of AIDS-associated Kaposi sarcoma in Mozambique after treatment with pegylated liposomal doxorubicin.

Authors:  Matthew E Coldiron; Ana Gabriela Gutierrez Zamudio; Rolanda Manuel; Gilda Luciano; Barbara Rusch; Iza Ciglenecki; Alex Telnov; Rebecca F Grais; Laurence Toutous Trellu; Lucas Molfino
Journal:  Infect Agent Cancer       Date:  2021-01-07       Impact factor: 2.965

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.